Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN8282,120,86
Msft-0,67
Nokia4,0014,0480,20
IBM1,87
Mercedes-Benz Group AG50,8550,87-1,34
PFE0,04
23.09.2025 7:30:51
Indexy online
AD Index online
select
AD Index online
 

  • 22.09.2025
Imperial Brands (IMT.F, Frankfurt)
Závěr k 22.9.2025 Změna (%) Změna (EUR) Objem obchodů (EUR)
35,60 0,42 0,15 20 583
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: Imperial Brands PLC is a fast-moving consumer goods company. The Company offers a range of cigarettes, fine cut and smokeless tobacco, papers, and cigars. The Company operates through two businesses: Tobacco & NGP and Distribution. The Tobacco & NGP business manufactures, markets, and sells tobacco and next-generation products (NGP) and tobacco and NGP-related products, including sales to (but not by) the Distribution business. The Distribution business distributes tobacco and NGP products for tobacco and NGP product manufacturers, including Imperial Brands, as well as a range of non-tobacco and NGP products and services. Its segments include Europe, Americas, Africa, Asia, Australasia and Central and Eastern Europe (AAACE) and Distribution. It brands include John Player Special, Davidoff, Gauloises, West, Winston, Kool, Lambert & Butler, Fortuna, Nobel, News, Backwoods, Champion, Golden Virginia, Maverick, Dutch Masters, Fine, Rizla, blu, Pulze, Skruf, and Zone.
Financial Summary: BRIEF: For the six months ended 31 March 2025, Imperial Brands PLC revenues decreased 3% to L14.6B. Net income decreased 4% to L808M. Revenues reflect Tobacco & NGP segment decrease of 5% to L9.25B, AAACE segment decrease of 11% to L2.72B, Europe segment decrease of 3% to L5.3B. Net income also reflects Tobacco & NGP segment income decrease of 2% to L1.29B, Distribution segment income decrease of 2% to L161M.



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorRobert Connelly6501.04.202501.06.2023
Principal Financial Officer, Principal Accounting Officer, Chief Strategy OfficerPreetam Shah5301.04.202524.03.2025
Executive Vice President, Head - Research and Development, Chief Medical OfficerChristopher Haqq5901.06.202301.06.2023
Chief Scientific OfficerPeter Demuth3801.06.202301.06.2023